Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuroone Medical Technologies (NMTC) Revenue (2020 - 2025)

Neuroone Medical Technologies (NMTC) has disclosed Revenue for 11 consecutive years, with $2.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Revenue fell 11.65% year-over-year to $2.9 million, compared with a TTM value of $8.7 million through Dec 2025, up 51.6%, and an annual FY2025 reading of $9.1 million, up 163.47% over the prior year.
  • Revenue was $2.9 million for Q4 2025 at Neuroone Medical Technologies, up from $2.7 million in the prior quarter.
  • Across five years, Revenue topped out at $3.3 million in Q4 2024 and bottomed at $18240.0 in Q1 2021.
  • Average Revenue over 5 years is $883680.6, with a median of $548041.0 recorded in 2023.
  • The sharpest move saw Revenue soared 1865.45% in 2023, then tumbled 63.29% in 2024.
  • Year by year, Revenue stood at $33748.0 in 2021, then skyrocketed by 239.51% to $114579.0 in 2022, then skyrocketed by 753.25% to $977649.0 in 2023, then skyrocketed by 234.9% to $3.3 million in 2024, then dropped by 11.65% to $2.9 million in 2025.
  • Business Quant data shows Revenue for NMTC at $2.9 million in Q4 2025, $2.7 million in Q3 2025, and $1.7 million in Q2 2025.